1 completed. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
Follow matuzumab: new trials by email Literature Review of matuzumab trials Research Report on matuzumab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety Study of EMD 72000 in Combination With ECX (Epirubicin, Cisplatin and Capecitabine) in Oesophagogastric Cancer EMD 72000 (matuzumab) + ECX - Esophageal Cancer, Gastric Cancer | Phase 1 | Completed | Merck KGaA, Darmstadt, Germany | 26 | 2002-10-01 | 2014-02-19 |
Adenocarcinoma Of Esophagus (1) · Esophageal Neoplasms (1) · Stomach Neoplasms (1)
Merck KGaA, Darmstadt, Germany (1)
United Kingdom (1)